The effect of bromelain capsules on stress and depressive anxiety in diabetic foot ulcer patients

Phase 3

Recruiting

• Conditions: Diabetic foot ulcer.; Type 1 diabetes mellitus with circulatory complications; E10.5

• Registration Number: IRCT20190708044148N2
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 2 May 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 88

Inclusion Criteria

Age 18 to 60 years
Informed consent
Mild or moderate score in DASS-21 pre-test

Exclusion Criteria

The patient is taking drugs that interact with bromelain
Patients enrolled in other clinical trial studies
History of other wounds

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Stress. Timepoint: Measurements before the study and 4 weeks after the start of the intervention. Method of measurement: Depression, Anxiety and Stress Questionnaire (DASS-21).;Anxiety. Timepoint: Measurements before the study and 4 weeks after the start of the intervention. Method of measurement: Depression, Anxiety and Stress Questionnaire (DASS-21).;Depression. Timepoint: Measurements before the study and 4 weeks after the start of the intervention. Method of measurement: Depression, Anxiety and Stress Questionnaire (DASS-21).